Elobixibat is a pharmaceutical raw material that functions as an inhibitor of the ileal bile acid transporter (IBAT). It has been investigated in clinical trials for the management of chronic constipation and irritable bowel syndrome with constipation.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 439087-18-0
Tert-Butyl Elobixibat
pharmaceutical intermediate
2-((3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetic acid
research compound
Odevixibat
pharmaceutical raw material
Linerixibat
pharmaceutical raw material
Lasmiditan
pharmaceutical raw material
Lasmiditan succinate
pharmaceutical raw material
Niflumic acid
pharmaceutical raw material
Eribulin mesylate
pharmaceutical raw material
2-[[(2R)-2-[[2-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydro-1lambda6,5-benzothiazepin-8-yl)oxy]acetyl]amino]-2-phenylacetyl]amino]acetic acid
XFLQIRAKKLNXRQ-UUWRZZSWSA-N
CCCCC1(CN(C2=CC(=C(C=C2S(=O)(=O)C1)OCC(=O)N[C@H](C3=CC=CC=C3)C(=O)NCC(=O)O)SC)C4=CC=CC=C4)CCCC